Lung Cancer Versus “Young Cancer”: Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?

…, K Hurdalkova, M Barinova, M Drosslerova… - Journal of adolescent …, 2022 - liebertpub.com
Purpose: Aim was to analyze demographic and tumor characteristics, treatment, and
survival of patients with lung cancer younger than 40 years of age (U40) compared to older …

[PDF][PDF] CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC)

M Drosslerova, M Sterclova, A Taskova… - Biomedical …, 2023 - biomed.papers.upol.cz
Background. Complex networks of chemokines are part of the immune reaction targeted
against tumor cells. Chemokines influence cancer growth. It is unclear whether the …

Can previous chemotherapy affect the outcome of nivolumab treatment in non-small cell lung cancer?

…, D Dolezal, O Bilek, J Krejci, M Drosslerova… - Anticancer …, 2022 - ar.iiarjournals.org
Aim: This study compared the results of nivolumab treatment in patients with pulmonary
adenocarcinomas based upon previous chemotherapeutic regimens. Patients and Methods: The …

Laboratory parameters associated with inflammation do not affect PD-L1 expression in non-small cell lung cancer

M Svaton, M Drosslerova, O Fischer, M Marel… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Due to some interconnectedness at the molecular level, this study assessed
the possible influence of laboratory parameters associated with systemic inflammatory …

[HTML][HTML] Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer

M Svaton, M Drosslerova, O Fischer… - Translational Cancer …, 2022 - ncbi.nlm.nih.gov
Background Programmed death-ligand 1 (PD-L1) expression is a standard predictor in the
selection of immunotherapy for locally advanced/advanced non-small cell lung cancer (…

[HTML][HTML] An ocular lesion of unknown aetiology

M Drosslerova, M Cernovska, M Vasakova, L Havel - Breathe, 2021 - Eur Respiratory Soc
A 61-year-old Caucasian female patient presented to her general practitioner complaining
of progressive diminished visual acuity, narrowed visual field and blurred vision in her right …

Preoperative evaluation of patients undergoing lung resection using cardiopulmonary exercise testing in predicting postoperative respiratory complications

A Tašková, M Drösslerová, K Brat, V Hytych… - 2018 - Eur Respiratory Soc
Background: Exercise testing is used in the preoperative evaluation and risk stratification of
lung resection candidates. Cardiopulmonary exercise testing (CPET) is increasingly used …

Role of chemokines, their gene polymorphisms in resectable NSCLC

M Drösslerová, M Šterclová, M Vašáková, A Tašková… - 2020 - Eur Respiratory Soc
Objectives: Chemokines are a part of immune reaction targeted against tumor. Chemokine
expression is influenced by gene polymorphisms. Their role isn9t clear in resectable NSCLC. …

Lung Cancer vs.„Young Cancer “–Is There a Difference?

M Bratová, K Hurdalkova, M Drosslerova, J Kultan… - 2021 - Eur Respiratory Soc
Introduction: Lung cancer is the leading cause of death among all cancer diseases worldwide.
Most of patients were in the age group of 65-69 years, however we also experience …

Lung cancer screening-screening trials.

M Drösslerová, M Vašáková, L Havel - 2020 - cabidigitallibrary.org
Lung cancer is the leading cause of cancer mortality. A complete cure can be achieved at
early stages of the disease thanks to lung resection surgery or radical radiotherapy. The …